The two panels (listed in Method) included a tumor-related marker (PANCK) for tumor and stroma recognition, two T-cell lineage markers (CD8 and FoxP3), and two TLS-related markers (CD20 and CD23) (Supplementary Fig. S3b, c). This evidence concerns the gene FCER2 and neoplasm.